Juan Manuel Carreño

MedicineAgricultural and Biological Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.3Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101079

Top 26%

0.782DataRank

Top 26%53 citations

Slim Fourati, Naresh Doni Jayavelu, Ravi K. Patel, Cole Maguire, Ana C. Chang +95 more

Papers

Driven by 58 papers — median percentile 69. Top paper: “Defining the risk of SARS-CoV-2 variants on immune protection”.

Defining the risk of SARS-CoV-2 variants on immune protection

Nature(2022)10.1038/s41586-022-04690-5

N/A

4.9DataRank · unranked

185 citations

Elodie Ghedin, Matthew B. Frieman, Florian Krammer, Alba Grifoni, Arghavan Alisoltani +95 more

Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial

EClinicalMedicine(2022)10.1016/j.eclinm.2022.101323

N/A

1.3DataRank · unranked

55 citations

Viravarn Luvira, Saranath Lawpoolsri, Sant Muangnoicharoen, Supitcha Kamolratanakul, Chaisith Sivakorn +42 more

Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico

npj Vaccines(2023)10.1038/s41541-023-00662-6

N/A

1.1DataRank · unranked

47 citations

Martha Torres, Luis Enrique Soto-Ramírez, Juan J. Calva, Patricio Santillán‐Doherty, Dora Eugenia Carranza-Salazar +28 more

Safety and immunogenicity of a live recombinant Newcastle disease virus-based COVID-19 vaccine (Patria) administered via the intramuscular or intranasal route: Interim results of a non-randomized open label phase I trial in Mexico

medRxiv(2022)10.1101/2022.02.08.22270676

N/A

1.1DataRank · unranked

26 citations

Martha Torres, Luis Enrique Soto-Ramírez, Juan J. Calva, Patricio Santillán‐Doherty, Dora Eugenia Carranza-Salazar +28 more

Study of efficacy and longevity of immune response to third and fourth doses of COVID-19 vaccines in patients with cancer: A single arm clinical trial

eLife(2023)10.7554/elife.83694

N/A

1.0DataRank · unranked

33 citations

Kith Pradhan, Benjamin Duva, Juan Manuel Carreño, Srabani Sahu, Victor Thiruthuvanathan +18 more

Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination

Cell Reports(2024)10.1016/j.celrep.2024.114922

N/A

0.805DataRank · unranked

37 citations

Irene Hoxie, Daniel C. Adelsberg, Iden A. Sapse, Robert Andreata‐Santos, Jeremy S. Yong +14 more

Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101079

Top 26%

0.782DataRank

Top 26%53 citations

Slim Fourati, Naresh Doni Jayavelu, Ravi K. Patel, Cole Maguire, Ana C. Chang +95 more

Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assays

Science Translational Medicine(2024)10.1126/scitranslmed.adl1722

Top 36%

0.541DataRank

Top 36%15 citations

Samuel Wilks, Lauren Baracco, Meriem Bekliz, Juan Manuel Carreño, Victor M. Corman +41 more

Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomised, Placebo-Controlled, Phase 1/2 Trial

medRxiv(2021)10.1101/2021.09.17.21263758

N/A

0.486DataRank · unranked

8 citations

Viravarn Luvira, Saranath Lawpoolsri, Sant Muangnoicharoen, Supitcha Kamolratanakul, Chaisith Sivakorn +41 more

Discovery of a SARS-CoV-2 Broadly-Acting Neutralizing Antibody with Activity against Omicron and Omicron + R346K Variants

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.19.476998

N/A

0.330DataRank · unranked

8 citations

Thomas Kraus, Heyue Zhou, Yanliang Zhang, Namir Shaabani, Soner Yildiz +43 more

Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model Sera

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.09.27.559689

N/A

0.301DataRank · unranked

4 citations

Samuel Wilks, Lauren Baracco, Meriem Bekliz, Juan Manuel Carreño, Victor M. Corman +41 more

Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: A randomised, comparator-controlled, phase 2 trial

Vaccine(2024)10.1016/j.vaccine.2024.126542

N/A

0.104DataRank · unranked

1 citations

Đặng Đức Anh, Vu Hai Ha, Nguyen Van Thom, Tran Cong Thang, José Mateus +14 more

Reduced neutralizing activity of post-SARS-CoV-2 vaccination serum against variants B.1.617.2, B.1.351, B.1.1.7+E484K and a sub-variant of C.37

medRxiv(2021)10.1101/2021.07.21.21260961

N/A

0DataRank · unranked

18 citations

Hala Alshammary, Gagandeep Singh, Ariel Raskin, Fatima Amanat, Angela A. Amoako +36 more

Reduced antibody activity against SARS-CoV-2 B.1.617.2 Delta virus in serum of mRNA-vaccinated patients receiving TNF-α inhibitors

medRxiv(2021)10.1101/2021.09.28.21264250

N/A

0DataRank · unranked

2 citations

Matthew J. Gorman, Daniel Y. Zhu, Juan Manuel Carreño, Dansu Yuan, Laura A. VanBlargan +18 more

Longitudinal analysis of SARS-CoV-2 seroprevalence using multiple serology platforms

medRxiv(2021)10.1101/2021.02.24.21252340

N/A

0DataRank · unranked

1 citations

Damodara Rao Mendu, Viviana Simon, Masood A Shariff, Gagandeep Singh, Vidya Menon +2 more

Household level SARS-CoV-2 sero-epidemiology in a high prevalence group of adults and children-implications for community infection control

American Journal of Infection Control(2021)10.1016/j.ajic.2021.08.015

N/A

0DataRank · unranked

0 citations

Juan Manuel Carreño, Sinai Serocore Team, Adam Polinger, Florian Krammer, Philip Zachariah +1 more

SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals

Nature Communications(2022)10.1038/s41467-022-32389-8

N/A

0DataRank · unranked

168 citations

Disha Bhavsar, Gagandeep Singh, Daniel Floda, Komal Srivastava, Charles Gleason +25 more

Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses

Nature Communications(2022)10.1038/s41467-022-32149-8

N/A

0DataRank · unranked

87 citations

Juan Manuel Carreño, George O’Dell, Jessica Tan, Csaba Bajusz, Hiromi Muramatsu +9 more

Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice

Microbiology Spectrum(2022)10.1128/spectrum.01538-22

N/A

0DataRank · unranked

42 citations

José Luis Martínez, Stefan Slamanig, Nicholas Lemus, Yonghong Liu, Tsoi Ying Lai +12 more

Antibodies targeting the neuraminidase active site inhibit influenza H3N2 viruses with an S245N glycosylation site

Nature Communications(2022)10.1038/s41467-022-35586-7

N/A

0DataRank · unranked

26 citations

Meagan McMahon, Hannah L. Turner, Xueyong Zhu, Hongquan Wan, Juan Manuel Carreño +11 more

Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutralizing antibody with activity against multiple Omicron subvariants

Med(2022)10.1016/j.medj.2022.08.002

N/A

0DataRank · unranked

23 citations

Thomas Kraus, Heyue Zhou, Yanliang Zhang, Namir Shaabani, Soner Yildiz +44 more

Longitudinal COVID-19-vaccination-induced antibody responses and Omicron neutralization in patients with lung cancer

Cancer Cell(2022)10.1016/j.ccell.2022.04.012

N/A

0DataRank · unranked

18 citations

Jorge Gómez, Ananda M. Rodilla, Juan Manuel Carreño, Chih–Yuan Hsu, Christian Rolfo +43 more

Novel Epitopes of the Influenza Virus N1 Neuraminidase Targeted by Human Monoclonal Antibodies

Journal of Virology(2022)10.1128/jvi.00332-22

N/A

0DataRank · unranked

17 citations

Kaori Sano, Meagan McMahon, Juan Manuel Carreño, Christina Capuano, Kaijun Jiang +5 more

Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapy

Multiple Sclerosis and Related Disorders(2022)10.1016/j.msard.2022.104486

N/A

0DataRank · unranked

15 citations

Sacha Gnjatic, Florian Krammer, Kevin Tuballes, Juan Manuel Carreño, Sammita Satyanarayan +16 more

Receptor binding domain (RBD) antibodies contribute more to SARS-CoV-2 neutralization when target cells express high levels of ACE2

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.08.29.505713

N/A

0DataRank · unranked

14 citations

Bernadeta Dadonaite, Allison J. Greaney, Rachel Eguia, Andrea N. Loes, Nicholas Franko +7 more

SARS-CoV-2 variants in the making: Sequential intrahost evolution and forward transmissions in the context of persistent infections

medRxiv(2022)10.1101/2022.05.25.22275533

N/A

0DataRank · unranked

13 citations

Hala Alshammary, Sarah Schaefer, Gopi Patel, José Polanco, Juan Manuel Carreño +24 more

mRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulations

medRxiv(2022)10.1101/2022.04.15.22273914

N/A

0DataRank · unranked

6 citations

Gagandeep Singh, Johnstone Tcheou, Komal Srivastava, Charles Gleason, Hiromi Muramatsu +8 more

Safety and Immunogenicity of An Egg-Based Inactivated Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomized, Placebo-Controlled, Phase 1/2 Trial in Vietnam

medRxiv(2022)10.1101/2022.02.01.22270253

N/A

0DataRank · unranked

3 citations

Vũ Đình Thiểm, Ha Hai Vu, Van Thanh Ta, Anh Thi Van Pham, Mai Thị Ngọc Đặng +28 more

Trivalent NDV-HXP-S vaccine protects against phylogenetically distant SARS-CoV-2 variants of concern in mice

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.21.485247

N/A

0DataRank · unranked

3 citations

José Luis Martínez, Stefan Slamanig, Nicholas Lemus, Yonghong Liu, Tsoi Ying Lai +11 more

Sequential intrahost evolution and onward transmission of SARS-CoV-2 variants

Nature Communications(2023)10.1038/s41467-023-38867-x

N/A

0DataRank · unranked

99 citations

Hala Alshammary, Sarah Schaefer, Gopi Patel, José Polanco, Juan Manuel Carreño +38 more

Nanovaccines Displaying the Influenza Virus Hemagglutinin in an Inverted Orientation Elicit an Enhanced Stalk‐Directed Antibody Response

Advanced Healthcare Materials(2023)10.1002/adhm.202202729

N/A

0DataRank · unranked

39 citations

Juan Manuel Carreño, Dominika Bielak, Ammar Arsiwala, Clara G. Altomare, Chad Varner +5 more

Mucosal antibody responses to SARS-CoV-2 booster vaccination and breakthrough infection

mBio(2023)10.1128/mbio.02280-23

N/A

0DataRank · unranked

21 citations

Gagandeep Singh, Kaori Sano, Charles Gleason, Komal Srivastava, PARIS study group +24 more

The post-COVID-19 population has a high prevalence of cross-reactive antibodies to spikes from all Orthocoronavirinae genera

mBio(2023)10.1128/mbio.02250-23

N/A

0DataRank · unranked

15 citations

Anass Abbad, Giulio Kleiner, Komal Srivastava, Charles Gleason, PARIS study group +22 more

Mucosal antibody responses to SARS-CoV-2 booster vaccination and breakthrough infection

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.08.24.554732

N/A

0DataRank · unranked

4 citations

Gagandeep Singh, Kaori Sano, Charles Gleason, Komal Srivastava, PARIS study group +4 more

The post-COVID-19 population has a high prevalence of crossreactive antibodies to spikes from all Orthocoronavirinae genera

medRxiv(2023)10.1101/2023.08.01.23293522

N/A

0DataRank · unranked

3 citations

Anass Abbad, Giulio Kleiner, Komal Srivastava, Charles Gleason, PARIS study group +4 more

Bivalent COVID-19 booster vaccines induce cross-reactive but not BA.5-specific antibodies in polyclonal serum

medRxiv(2023)10.1101/2023.04.12.23288362

N/A

0DataRank · unranked

2 citations

Gagandeep Singh, Anass Abbad, Temima Yellin, Komal Srivastava, Charles Gleason +5 more

SARS-CoV-2 serosurvey across multiple waves of the COVID-19 pandemic in New York City between 2020-2023

medRxiv(2023)10.1101/2023.12.18.23300131

N/A

0DataRank · unranked

2 citations

Abram L. Wagner, Brian Monahan, Daniel Floda, Ana S. Gonzalez‐Reiche, Johnstone Tcheou +14 more

SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase

Immunity(2024)10.1016/j.immuni.2024.01.017

N/A

0DataRank · unranked

144 citations

Juan Manuel Carreño, Charles Gleason, Brian Monahan, Gagandeep Singh, Anass Abbad +48 more

Maturation of germinal center B cells after influenza virus vaccination in humans

The Journal of Experimental Medicine(2024)10.1084/jem.20240668

N/A

0DataRank · unranked

31 citations

Hailong Meng, Ting-Hui Lin, Wooseob Kim, Nina E. Moore, Julianna Han +20 more

SARS-CoV-2 serosurvey across multiple waves of the COVID-19 pandemic in New York City between 2020–2023

Nature Communications(2024)10.1038/s41467-024-50052-2

N/A

0DataRank · unranked

17 citations

Abram L. Wagner, Brian Monahan, Gagandeep Singh, Daniel Floda, Ana S. Gonzalez‐Reiche +27 more

SARS-CoV-2 BA.1 and BA.2 breakthrough infections boost antibody responses to early Omicron subvariants but not BQ.1.1 or XBB.1.5

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101474

N/A

0DataRank · unranked

8 citations

Temima Yellin, Gagandeep Singh, M. Fried, Ariel Raskin, Johnstone Tcheou +23 more

SARS-CoV-2 infection, inflammation and birth outcomes in a prospective NYC pregnancy cohort

Journal of Reproductive Immunology(2024)10.1016/j.jri.2024.104243

N/A

0DataRank · unranked

8 citations

Rebecca H. Jessel, Elianna Kaplowitz, Natalie Boychuk, Sophie Ohrn, Erona Ibroçi +27 more

Time-Dependent Effects of Clinical Interventions on SARS-CoV-2 Immunity in Patients with Lung Cancer

Vaccines(2024)10.3390/vaccines12070713

N/A

0DataRank · unranked

1 citations

Chih–Yuan Hsu, Ananda M. Rodilla, Jorge Gómez, Jazz Cagan, Yuanhui Huang +19 more

Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.02.28.582613

N/A

0DataRank · unranked

9 citations

Irene Hoxie, Daniel C. Adelsberg, Iden A. Sapse, Robert Andreata‐Santos, Jeremy S. Yong +14 more

Influenza vaccine based on AS03-adjuvanted chimeric HA induces long-lived stalk-specific plasma cells in bone marrow and lymph nodes of nonhuman primates

Nature Immunology(2025)10.1038/s41590-025-02309-1

N/A

0DataRank · unranked

1 citations

Tiffany M. Styles, Chunyang Gu, André Nicolás León, Gregory K. Tharp, Kasey Stokdyk +19 more

Real-Time Investigation of a Large Nosocomial Influenza A Outbreak Informed by Genomic Epidemiology

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1781

N/A

0DataRank · unranked

23 citations

Jordan Ehni, Ana S. Gonzalez‐Reiche, Juan Manuel Carreño, Elena Hirsch, Jessica Tan +22 more

Humoral SARS-CoV-2 vaccine responses are durable in solid organ transplant recipients with and without HIV

Vaccine(2025)10.1016/j.vaccine.2025.127969

N/A

0DataRank · unranked

0 citations

Brandy Haydel, Gina Carrara, Charles Gleason, Jacob Mauldin, Komal Srivastava +12 more

Real Time Investigation of a large Nosocomial Influenza A Outbreak Informed by Genomic Epidemiology

medRxiv(2020)10.1101/2020.05.10.20096693

N/A

0DataRank · unranked

6 citations

Jordan Ehni, Ana S. Gonzalez‐Reiche, Juan Manuel Carreño, Elena Hirsch, Jessica Tan +22 more

Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron

Nature(2021)10.1038/s41586-022-04399-5

N/A

0DataRank · unranked

533 citations

Hala Alshammary, Johnstone Tcheou, Gagandeep Singh, Ariel Raskin, Hisaaki Kawabata +38 more

SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2

Cell(2021)10.1016/j.cell.2021.06.005

N/A

0DataRank · unranked

313 citations

Mahima Thapa, Tinting Lei, Shaza M. Sayed Ahmed, Daniel C. Adelsberg, Juan Manuel Carreño +42 more

Evidence for retained spike-binding and neutralizing activity against emerging SARS-CoV-2 variants in serum of COVID-19 mRNA vaccine recipients

EBioMedicine(2021)10.1016/j.ebiom.2021.103626

N/A

0DataRank · unranked

55 citations

Hala Alshammary, Gagandeep Singh, Ariel Raskin, Fatima Amanat, Angela A. Amoako +10 more

Reduced antibody activity against SARS-CoV-2 B.1.617.2 delta virus in serum of mRNA-vaccinated individuals receiving tumor necrosis factor-α inhibitors

Med(2021)10.1016/j.medj.2021.11.004

N/A

0DataRank · unranked

36 citations

Matthew J. Gorman, Daniel Y. Zhu, Juan Manuel Carreño, Dansu Yuan, Laura A. VanBlargan +18 more

Mutations in the Hemagglutinin Stalk Domain Do Not Permit Escape from a Protective, Stalk-Based Vaccine-Induced Immune Response in the Mouse Model

mBio(2021)10.1128/mbio.03617-20

N/A

0DataRank · unranked

37 citations

Juan Manuel Carreño, Meagan McMahon, Kaijun Jiang, Harm van Bakel, Patrick C. Wilson +2 more

Identification and Characterization of Novel Antibody Epitopes on the N2 Neuraminidase

mSphere(2021)10.1128/msphere.00958-20

N/A

0DataRank · unranked

24 citations

Meagan McMahon, Juan Manuel Carreño, Christina Capuano, Kaijun Jiang, Viviana Simon +4 more

Longitudinal analysis of severe acute respiratory syndrome coronavirus 2 seroprevalence using multiple serology platforms

iScience(2021)10.1016/j.isci.2021.102937

N/A

0DataRank · unranked

15 citations

Damodara Rao Mendu, Viviana Simon, Masood A Shariff, Gagandeep Singh, Vidya Menon +2 more

Refocusing the Immune Response to Selected Epitopes on a Zika Virus Protein Antigen by Nanopatterning

Advanced Healthcare Materials(2021)10.1002/adhm.202002140

N/A

0DataRank · unranked

12 citations

Juan Manuel Carreño, James Duehr, Florian Krammer, Ravi S. Kane, Ana Hortência Fônseca Castro

Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.08.25.457693

N/A

0DataRank · unranked

29 citations

Bradley Whitener, Laura A. VanBlargan, Ahmed O. Hassan, Swathi Shrihari, Chieh-Yu Liang +15 more

Efficient mucosal antibody response to SARS-CoV-2 vaccination is induced in previously infected individuals

medRxiv(2021)10.1101/2021.12.06.21267352

N/A

0DataRank · unranked

23 citations

Disha Bhavsar, Gagandeep Singh, Daniel Floda, Komal Srivastava, Charles Gleason +5 more

Juan Manuel Carreño

Indexed papers

Top data-sharing exemplar

Papers